FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Net Income 2020–2025
FibroGen, Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- FibroGen, Inc. net income for the quarter ending March 31, 2026 was -15.2 M, a 427.61% decrease year-over-year.
- FibroGen, Inc. net income for the twelve months ending March 31, 2026 was 163.6 M.
- FibroGen, Inc. annual net income for 2025 was 183.5 M, a 485.57% decrease from 2024.
- FibroGen, Inc. annual net income for 2024 was -47.6 M, a 83.26% decrease from 2023.
- FibroGen, Inc. annual net income for 2023 was -284.2 M, a 3.21% decrease from 2022.
- FibroGen, Inc. annual net income for 2022 was -293.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
FibroGen, Inc. Net Income — FAQ
FibroGen, Inc. (KYNB) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is FibroGen, Inc.'s net income?
FibroGen, Inc. (KYNB) reported net income of $183M for fiscal 2025.
Where can I see KYNB's net income history?
The chart and table above show FibroGen, Inc.'s net income by year and by quarter, including the growth rate.